S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
A sudden and dramatic change is coming to US bank accounts. (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
The perfect AI stock under $10 (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
A sudden and dramatic change is coming to US bank accounts. (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
The perfect AI stock under $10 (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
A sudden and dramatic change is coming to US bank accounts. (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
The perfect AI stock under $10 (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
A sudden and dramatic change is coming to US bank accounts. (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
The perfect AI stock under $10 (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
OTCMKTS:BITGF

Biotage AB (publ) (BITGF) Stock Price, News & Analysis

$16.50
0.00 (0.00%)
(As of 02/20/2024 ET)
Today's Range
$16.50
$16.50
50-Day Range
$12.00
$16.50
52-Week Range
$8.00
$16.50
Volume
N/A
Average Volume
171 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BITGF stock logo

About Biotage AB (publ) Stock (OTCMKTS:BITGF)

Biotage AB (publ) provides solution and product in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation product; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, academic, environmental protection, food safety, and agriculture, as well as clinical, forensic, and academic laboratories. It operates in 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.

BITGF Stock Price History

BITGF Stock News Headlines

Biotage AB (publ) (OTCMKTS:BITGF) Trading 37.5% Higher
EVGGF Evolution AB (publ)
How to profit from the new boom in gold
Gold just passed $2,000/oz and is set for a new bull run in 2024. Now a renowned precious metals expert is sharing his No. 1 way to play it for just $5. 
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT APRIL 2023
Vimian Group AB (publ) reports Q1 results
Biotage AB
Biotage AB (publ) (BIOT.ST)
The perfect AI stock under $10
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. This #1 AI company is at the forefront of it all.
CMO to leave HMS Networks AB (publ)
Lifco publ AB (LIFCOb)
Biotage AB (publ) publishes new Financial Goals
BITGF After-Hours Quotes
Biotage Awarded Gold Sustainability Medal by EcoVadis
Biotage AB (publ) Year-end report January - December 2021
Biotage moves to the large cap segment
Change in number of shares and votes
Biotage - Change in number of shares and votes
Biotage AB (publ) Interim report January - September 2021
Biotage A earnings preview: what Wall Street is expecting
Biotage appoints Nomination Committee
See More Headlines
Receive BITGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotage AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:BITGF
CIK
N/A
Fax
N/A
Employees
689
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Torben Jorgensen B.Sc. (Age 72)
    Interim CEO, President & Director
    Comp: $817k
  • Mr. Andrew Kellett (Age 55)
    Interim Chief Financial Officer
  • Mr. Anders Wikstrom BSc (Age 51)
    CS, Executive Vice President of Operations
  • Raffaella Bombarda (Age 50)
    EVP of Global Marketing
  • Ms. Petra Duprez (Age 59)
    Chief Human Resources & Sustainability Officer
  • Mr. Scott Carr (Age 57)
    President of Americas & Chief/Head of Americas
  • Mr. Jonas Stahlberg (Age 49)
    Chief Auditor
  • Mr. Olof Nord (Age 49)
    Executive Vice President of Business Development
  • Mr. Andreas Juhlin (Age 50)
    President of International - EMEA and APAC
  • Mr. Magnus Nordstedt (Age 54)
    Executive Vice President of IT & Digitalization














BITGF Stock Analysis - Frequently Asked Questions

Should I buy or sell Biotage AB (publ) stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Biotage AB (publ) in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" BITGF shares.
View BITGF analyst ratings
or view top-rated stocks.

How have BITGF shares performed in 2024?

Biotage AB (publ)'s stock was trading at $12.00 at the start of the year. Since then, BITGF shares have increased by 37.5% and is now trading at $16.50.
View the best growth stocks for 2024 here
.

How do I buy shares of Biotage AB (publ)?

Shares of BITGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BITGF) was last updated on 2/21/2024 by MarketBeat.com Staff